PMA supplement
P160048 S016: Eversense® E3 Continuous Glucose Monitoring System
FDA PMA supplement · Panel Track · Senseonics, Incorporated
Key facts
| Original PMA | P160048 |
|---|---|
| Supplement number | S016 |
| Supplement type | Panel Track |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | Eversense® E3 Continuous Glucose Monitoring System |
| Generic name | Sensor, glucose, implanted, non-adjunctive use |
| Applicant | Senseonics, Incorporated |
| Product code | QHJ |
| Received date | Sep 30, 2020 |
| Decision date | Feb 10, 2022 |
| Docket number | 22M-0171 |
| Notice date | Feb 15, 2022 |
At a glance
- No Expedited review granted
- Yes Approval order on file
- Yes Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: